Impact (REF3a/b)

Impact template (REF3a)

Download template (144K)

All impact case studies

Download all case studies (2.2MB)

Individual case studies

Defining the phenotype of severe growth disorders, discovering new genes that control human growth and enhancing clinical practice (243K)

Design and implementation of a new treatment for dysphagia after stroke (126K)

Developing the evidence base for a changing cervical screening programme in England (119K)

Development and application of inhaled therapies in airway diseases (195K)

Diagnostics and novel life-saving therapies for aspergillosis (276K)

Establishing the evidence for treatment to improve outcomes in patients with lung cancer (130K)

Fibrillin-rich microfibrils and efficacy of anti-ageing cosmetics (197K)

Improved clinical management of lysosomal disorders (187K)

Improved management of population cardiovascular risk in diabetic patients (145K)

Improving outcomes for children with leukaemia internationally: the results of scientifically designed clinical trials and translational research (129K)

Improving outcomes of women diagnosed with and at increased risk of breast cancer: the results of translational research and national and international clinical trials (180K)

Improving treatment outcomes for patients with rheumatoid arthritis (126K)

Preventing bone loss in patients treated for breast cancer (124K)

The global impact of gene identification at the University of Manchester (127K)

The University of Manchester’s role in establishing nationally funded forefront services for neurofibromatoses (123K)